14 December 2023
Science, Science & Technology
Former EMBL staff scientist founds a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
2023
sciencescience-technology
6 July 2023
Connections, Lab Matters
Through the collaborative framework agreement, EMBL and ZEISS aim to accelerate the development of imaging technology to advance life science research.
2023
connectionslab-matters
14 June 2023
Lab Matters, People & Perspectives
Jürgen Bauer talks about translating science into applications with societal benefit, his journey from the lab bench to business development, and technology transfer at EMBL.
2023
lab-matterspeople-perspectives
7 February 2023
Connections, Lab Matters
One of EMBL’s core missions is the development and transfer of scientific know-how and technologies to academia, industry, and commercial entities to facilitate further research, innovations, and commercialisation for the benefit of society at large. Working across Europe, EMBL has partnerships…
2023
connectionslab-matters
2 June 2022
Connections, Lab Matters
A new formal collaboration agreement enables will help smooth the transition from fundamental science to innovation.
2022
connectionslab-matters
8 February 2022
Alumni, Lab Matters, Science & Technology, Technology and innovation
Experiences at EMBL Rome led former group leader to establish his start-up in Italy, developing a new generation of gene therapies.
2022
alumnilab-mattersscience-technologytechnology-and-innovation
13 April 2021
Lab Matters, Science & Technology
Florent Cipriani, who recently retired as Head of the Instrumentation Team after a long career at EMBL Grenoble, is one of the pioneers of instrumentation development in this field.
2021
lab-mattersscience-technology
8 July 2020
Lab Matters
The CrystalDirect® technology, combined with the web-based CRIMS software enable a fully automated, remote-controlled protein-to-structure pipeline.
8 July 2019
Lab Matters
Reflecting on 20 years of EMBLEM
7 March 2018
Lab Matters, Science & Technology
New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies
2018
lab-mattersscience-technology
8 May 2017
Connections, Lab Matters
Accelerating researchers’ access to next-generation light-sheet microscopy
2017
connectionslab-matters
16 February 2017
Connections, Lab Matters
GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
2017
connectionslab-matters
17 December 2015
Science, Science & Technology
From initial development to a start-up company: Selective Plane Illumination Microscopy (SPIM) at EMBL.
2015
sciencescience-technology
14 October 2015
Lab Matters, Science & Technology
A microscopy technique is poised to shine new light on biological questions: as sheets of light can scan everything from developing embryos to single cells or functioning brains, a technique called light-sheet microscopy is gaining traction. It enables scientists to observe living cells in three…
2015
lab-mattersscience-technology
31 March 2005
Lab Matters
A novel high-tech microscope will be brought to the marketplace, giving laboratories everywhere fascinating new insights into living organisms. EMBLEM Technology Transfer GmbH (EMBLEM), the commercial entity of the European Molecular Biology Laboratory (EMBL), announced today that it has signed a…
No matching posts found